In the presence of lenalidomide, the levels of GPR68 transcript and protein are upregulated in MDSL cells as well as primary MDS cells and normal CD34+ hematopoietic stem and progenitor cells (HSPCs). The gene discussed is CD34; the disease is myelodysplastic syndrome.